Delivery Order SPE2DB22D2214-SPE2DB25FS3LS

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,225.71 firm-fixed-price delivery order contract is for the supply of RINVOQ ER 30 MG TABLET medical products. The contract has a period of performance through February 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,901.70, is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,022.66 firm fixed-price delivery order contract is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, with a completion date of January 7, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,015.85 firm fixed price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,024.41 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a medication, with a completion date of February 4, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,751.55 Firm Fixed Price Delivery Order is for the supply of RINVOQ ER 30 MG TABLET, a prescription medication. The contract has an ultimate completion date of February 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET medical products. The contract has a completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,551.66 contract is a firm fixed-price delivery order for the supply of the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $20,232.96 firm fixed-price delivery order is for RINVOQ ER 30 MG TABLET, a medical supply item. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm-fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a specialty medication, with a completion date of November 22, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS3LS
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,828.93 firm-fixed price delivery order contract is for the supply of RINVOQ ER 30 MG TABLET medical products.

The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the requested medical products to fulfill the DLA's requirements for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/22/25, 11:44 AM